Results from the 1st quarter 2017 for Medistim ASA
Results from the 1st quarter 2017 for Medistim ASA
Sales for the quarter ended at MNOK 74.4 (MNOK 65.5), an
increase of 13.5 %. Currency neutral growth of own products
was 20.3 %. Operating profit (EBIT) ended at MNOK 16.0 (MNOK
13.5), up 18.4 %. Sales from the US continues to grow and
increased with 9.6 % in USD. Medistim established a sales
organization through a new subsidiary in Spain during the
first quarter. The General Meeting decided to pay a
dividend of NOK 1.75 per share.